No significant difference of PALB2 IHC score was detected in breast cancer patients with different stage (higher vs lower), lymph nodes status (positive vs negative), ER status (positive vs negative) and PR status (positive vs negative). The gene discussed is ESR1; the disease is breast carcinoma.